トランスフェクション技術市場 : 2028年までの世界予測

Report Overview

The transfection technologies market is projected to reach USD 1.8 billion by 2028 from an estimated USD 1.2 billion in 2023, at a CAGR of 9.4% during the forecast period.

トランスフェクション技術市場は、予測期間中のCAGR 9.4%で、2023年の推定12億ドルから2028年までに18億ドルに達すると予測されています。

The growth of this market can be attributed to the technological advancements in physical transfection methods, increasing research and development efforts in cell biology, growing focus on personalized medicines, and rising demand for advanced therapeutic products.

“The kits & reagents segment accounted for the largest share by product type in 2022.”
In 2022, the kits & reagents segment accounted for the largest share of product type in the global transfection technologies market. The factors like growing demand for high quality reagents to transfect nucleic acids into cells. The increasing focus on development of personalized medicines is also driving the growth of this market. Furthermore, the market share of the kits & reagents market is expected to grow simultaneously with the increasing need for advanced therapies.

 “The North America dominated the transfection technologies market during the forecast period of 2023-2028.”
North America dominated the global transfection technologies market in 2022. This dominance is attributed to the presence of academic and research centers, often associated with drug discovery and development. Additionally, the region is experiencing increased investments in biologics and advanced dosage forms. The growing need to expedite the drug development process, which typically spans 10 to 12 years, has further fueled the demand for transfection technologies. Consequently, the North America market is witnessing growth due to the development of novel drug products and the growing research and development in cell biology efforts in the region.

The primary interviews conducted for this report can be categorized as follows:
• By Respondent: Supply Side- 70% and Demand Side 30%
• By Designation: Managers – 45%, CXO & Directors – 30%, and Executives – 25%
• By Region: North America -35%, Europe -20%, Asia-Pacific -25%, Latin America -15% and Middle East & Africa- 5%

List of Companies Profiled in the Report:
• Thermo Fisher Scientific Inc. (US)
• Bio-Rad Laboratories, Inc. (US)
• QIAGEN (Netherlands)
• Merck KGaA (Germany)
• Sartorius AG (Polyplus) (Germany)
• Lonza (Switzerland)
• F. Hoffmann-La Roche Ltd (Switzerland)
• Agilent Technologies, Inc. (US)
• MaxCyte (US)
• Revvity (US)
• Takara Bio Inc. (Japan)
• Promega Corporation (US)
• Danaher Corporation (US)
• BOC Sciences (US)
• RJH BIOSCIENCES (Canada)
• Synvolux (Netherlands)
• Altogen Biosciences (US)
• BioIVT (US)
• Incella GmbH (Germany)
• InvivoGen (France)
• Phoreus Biotech (US)
• STEMCELL Technologies (Canada)
• EZ Biosystems (US)
• OZ Biosciences  (France)
• chemicell GmbH (Germany)

Research Coverage:
This research report categorizes the transfection technologies market by product type (kits & reagents and equipment), method (physical transfection (electroporation, bistolic technology, microinjection, and other physical transfection methods), biochemical transfection (lipofection, calcium phosphate, cationic polymer, dendrimer mediated transfection, and DEAE dextran), viral vector transfection), application (biomedical research, therapeutic delivery, protein production, and cell based microarray), end user (pharmaceutical and biotechnology companies, Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), academic and research institutes, and other end users)
The report’s scope encompasses detailed information regarding major influencing factors such as drivers, trends, challenges, and opportunities shaping the growth of the transfection technologies market. A comprehensive analysis of key industry players has been conducted to offer insights into their business overview, products, key strategies, collaborations, partnerships, and agreements. The report also covers recent developments, including new product launches, mergers, and acquisitions, in the transfection technologies market.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall transfection technologies market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:
• Analysis of key drivers (Increasing demand for cell and gene therapy, rising research activities and R&D funding, technological advancements), restraints (limited efficiency of transfection methods, adoption of alternative methods), opportunities (rising focus on personalized medicine, growth opportunities in emerging economies), and challenges (concerns related to cytotoxicity and transfection in hard-to-transfect cells, challenges associated with large scale transfection processes) influencing the growth of the market.
• Product Development/Innovation: Detailed insights on newly launched products of the transfection technologies market
• Market Development: Comprehensive information about lucrative markets – the report analyses the market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the transfection technologies market
• Competitive Assessment: Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), QIAGEN (Netherlands),  Merck KGaA (Germany), Sartorius AG (Polyplus) (Germany), Lonza (Switzerland), F. Hoffmann-La Roche Ltd (Switzerland), Agilent Technologies, Inc. (US), MaxCyte (US), Revvity (US), Takara Bio Inc. (Japan), Promega Corporation (US), Danaher Corporation (US), BOC Sciences (US), RJH BIOSCIENCES (Canada), Synvolux (Netherlands), Altogen Biosciences (US), BioIVT (US), Incella GmbH (Germany), InvivoGen (France), Phoreus Biotech (US), STEMCELL Technologies (Canada), EZ Biosystems (US), OZ Biosciences  (France), chemicell GmbH (Germany), and among others in the market. 

Table of Contents

1            INTRODUCTION            56

1.1         STUDY OBJECTIVES      56

1.2         MARKET DEFINITION   57

1.2.1      INCLUSIONS AND EXCLUSIONS 57

1.3         STUDY SCOPE  58

1.3.1      MARKETS COVERED     58

1.3.2      YEARS CONSIDERED     59

1.3.3      CURRENCY CONSIDERED          59

1.4         STAKEHOLDERS            59

1.5         SUMMARY OF CHANGES            60

1.6         RECESSION IMPACT      60

2            RESEARCH METHODOLOGY     61

2.1         RESEARCH DATA           61

FIGURE 1           RESEARCH DESIGN       61

2.1.1      SECONDARY DATA       62

2.1.2      PRIMARY DATA 63

FIGURE 2           TRANSFECTION TECHNOLOGIES MARKET: BREAKDOWN OF PRIMARIES        63

2.2         MARKET SIZE ESTIMATION       64

2.2.1      BOTTOM-UP APPROACH           64

FIGURE 3           TRANSFECTION TECHNOLOGIES MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2022 64

FIGURE 4           MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2022             65

FIGURE 5           ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS, 2022  65

2.2.1.1   Insights from primaries      67

FIGURE 6           MARKET VALIDATION FROM PRIMARY EXPERTS           67

2.2.2      TOP-DOWN APPROACH             67

FIGURE 7           MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH       67

2.3         GROWTH RATE ASSUMPTIONS/GROWTH FORECAST    68

FIGURE 8           TRANSFECTION TECHNOLOGIES MARKET: CAGR PROJECTIONS  69

FIGURE 9           TRANSFECTION TECHNOLOGIES MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES              69

2.4         MARKET BREAKDOWN AND DATA TRIANGULATION    70

FIGURE 10         DATA TRIANGULATION METHODOLOGY         70

2.5         RESEARCH ASSUMPTIONS         71

2.6         LIMITATIONS   71

2.7         RISK ANALYSIS 72

2.8         RECESSION IMPACT ANALYSIS 72

3            EXECUTIVE SUMMARY 73

FIGURE 11         TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)             73

FIGURE 12         TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2023 VS. 2028 (USD MILLION)             74

FIGURE 13         TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)     74

FIGURE 14         TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)             75

FIGURE 15         TRANSFECTION TECHNOLOGIES MARKET: GEOGRAPHIC ANALYSIS          76

4            PREMIUM INSIGHTS      77

4.1         TRANSFECTION TECHNOLOGIES MARKET OVERVIEW 77

FIGURE 16         GROWING DEMAND FOR CELL AND GENE THERAPY TO DRIVE MARKET GROWTH        77

4.2         ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT AND COUNTRY         78

FIGURE 17         KITS & REAGENTS HELD LARGEST SHARE OF ASIA PACIFIC MARKET IN 2022             78

4.3         TRANSFECTION TECHNOLOGIES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES           79

FIGURE 18         INDIA TO REGISTER HIGHEST CAGR IN GLOBAL TRANSFECTION TECHNOLOGIES MARKET OVER FORECAST PERIOD    79

4.4         TRANSFECTION TECHNOLOGIES MARKET SHARE, BY PRODUCT, 2022              79

FIGURE 19         KITS & REAGENTS HELD LARGEST SHARE OF PRODUCTS MARKET IN 2022             79

5            MARKET OVERVIEW     80

5.1         INTRODUCTION            80

5.2         MARKET DYNAMICS     80

FIGURE 20         TRANSFECTION TECHNOLOGIES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES       80

TABLE 1             TRANSFECTION TECHNOLOGIES MARKET: IMPACT ANALYSIS              81

5.2.1      DRIVERS            81

5.2.1.1   Increasing demand for cell and gene therapy  81

FIGURE 21         ESTIMATED CANCER CASELOAD, BY REGION   82

FIGURE 22         COMPARATIVE DATA FOR TOTAL NUMBER OF CLINICAL TRIALS 82

5.2.1.2   Rising research activity and R&D funding      83

5.2.1.3   Alliances for developing advanced therapeutic products             83

5.2.1.4   Expanded applications of transfection technologies      84

5.2.1.5   Technological advancements           84

5.2.2      RESTRAINTS     85

5.2.2.1   Limited efficiency of transfection methods     85

5.2.2.2   High cost of transfection products    85

5.2.2.3   Adoption of alternative methods      86

5.2.3      OPPORTUNITIES           86

5.2.3.1   Rising focus on personalized medicines          86

5.2.3.2   Growth opportunities in emerging economies 86

5.2.4      CHALLENGES   87

5.2.4.1   Concern related to cytotoxicity and transfection in hard-to-transfect cells 87

5.2.4.2   Challenges associated with large-scale transfection processes     87

5.3         PORTER’S FIVE FORCES ANALYSIS         87

TABLE 2             TRANSFECTION TECHNOLOGIES MARKET: PORTER’S FIVE FORCES ANALYSIS         87

5.3.1      THREAT OF NEW ENTRANTS    88

5.3.2      THREAT OF SUBSTITUTES         88

5.3.3      BARGAINING POWER OF SUPPLIERS     88

5.3.4      BARGAINING POWER OF BUYERS           88

5.3.5      INTENSITY OF COMPETITIVE RIVALRY 88

5.4         ECOSYSTEM/MARKET MAP       89

FIGURE 23         TRANSFECTION TECHNOLOGIES MARKET: ECOSYSTEM              89

5.4.1      PRODUCT VENDORS    90

TABLE 3             TRANSFECTION TECHNOLOGIES MARKET: PRODUCT VENDORS          90

5.4.2      END USERS       91

TABLE 4             TRANSFECTION TECHNOLOGIES MARKET: END USERS 91

5.4.3      REGULATORY BODIES  91

TABLE 5             TRANSFECTION TECHNOLOGIES MARKET: REGULATORY BODIES 91

5.5         SUPPLY CHAIN ANALYSIS          92

FIGURE 24         TRANSFECTION TECHNOLOGIES MARKET: SUPPLY CHAIN ANALYSIS          92

5.6         VALUE CHAIN ANALYSIS            93

FIGURE 25         VALUE CHAIN ANALYSIS OF TRANSFECTION TECHNOLOGIES MARKET: R&D AND MANUFACTURING PHASES ADD MAXIMUM VALUE 93

5.7         REGULATORY LANDSCAPE       95

5.7.1      REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS          95

TABLE 6             NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         95

TABLE 7             EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96

TABLE 8             ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         96

TABLE 9             REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         97

5.8         PRICING ANALYSIS        97

TABLE 10           AVERAGE SELLING PRICE, BY COMPANY, 2022  98

TABLE 11           AVERAGE SELLING PRICE, BY REGION  98

5.9         TECHNOLOGY ANALYSIS           99

TABLE 12           TRANSFECTION TECHNOLOGIES MARKET: PROMINENT TECHNOLOGIES AND THEIR IMPACTS 99

5.10       PATENT ANALYSIS        100

FIGURE 26         PATENT APPLICATIONS FOR TRANSFECTION TECHNOLOGIES MARKET, JANUARY 2013–OCTOBER 2023             100

TABLE 13           TRANSFECTION TECHNOLOGIES MARKET: INDICATIVE LIST OF PATENTS     101

5.11       KEY CONFERENCES AND EVENTS, 2024–2025     102

TABLE 14           TRANSFECTION TECHNOLOGIES MARKET: DETAILED LIST OF CONFERENCES AND EVENTS, 2024–2025             102

5.12       TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 103

FIGURE 27         REVENUE SHIFT AND NEW POCKETS FOR TRANSFECTION PRODUCT PROVIDERS 103

5.13       KEY STAKEHOLDERS AND BUYING CRITERIA    104

5.13.1    KEY STAKEHOLDERS IN BUYING PROCESS         104

FIGURE 28         INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TRANSFECTION PRODUCTS     104

5.13.2    BUYING CRITERIA FOR TRANSFECTION PRODUCTS      105

FIGURE 29         KEY BUYING CRITERIA FOR END USERS              105

TABLE 15           KEY BUYING CRITERIA FOR END USERS              105

6            TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT          107

6.1         INTRODUCTION            108

TABLE 16           TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)          108

6.2         KITS & REAGENTS         108

6.2.1      KITS & REAGENTS SEGMENT TO HOLD LARGEST SHARE OF PRODUCTS MARKET     108

TABLE 17           TRANSFECTION KITS & REAGENTS MARKET, BY REGION, 2021–2028 (USD MILLION)     109

TABLE 18          NORTH AMERICA: TRANSFECTION KITS & REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)            109

TABLE 19           EUROPE: TRANSFECTION KITS & REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    110

TABLE 20           ASIA PACIFIC: TRANSFECTION KITS & REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    110

TABLE 21           LATIN AMERICA: TRANSFECTION KITS & REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)            111

TABLE 22           MIDDLE EAST & AFRICA: TRANSFECTION KITS & REAGENTS MARKET, BY REGION, 2021–2028 (USD MILLION)            111

TABLE 23           MIDDLE EAST: TRANSFECTION KITS & REAGENTS MARKET, BY REGION, 2021–2028 (USD MILLION)       111

6.3         EQUIPMENT     112

6.3.1      TECHNOLOGICAL DEVELOPMENTS AND RISING ADOPTION OF INNOVATIVE PRODUCTS TO BOOST MARKET GROWTH            112

TABLE 24           TRANSFECTION EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION) 112

TABLE 25           NORTH AMERICA: TRANSFECTION EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    112

TABLE 26          EUROPE: TRANSFECTION EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          113

TABLE 27           ASIA PACIFIC: TRANSFECTION EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    113

TABLE 28           LATIN AMERICA: TRANSFECTION EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    114

TABLE 29           MIDDLE EAST & AFRICA: TRANSFECTION EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION)            114

TABLE 30           MIDDLE EAST: TRANSFECTION EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION)       114

7            TRANSFECTION TECHNOLOGIES MARKET, BY METHOD           115

7.1         INTRODUCTION            116

TABLE 31           TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)     116

7.2         PHYSICAL TRANSFECTION        116

TABLE 32           PHYSICAL TRANSFECTION MARKET, BY REGION, 2021–2028 (USD MILLION) 117

TABLE 33           NORTH AMERICA: PHYSICAL TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    117

TABLE 34           EUROPE: PHYSICAL TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          118

TABLE 35           ASIA PACIFIC: PHYSICAL TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    118

TABLE 36           LATIN AMERICA: PHYSICAL TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    119

TABLE 37           MIDDLE EAST & AFRICA: PHYSICAL TRANSFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)  119

TABLE 38           MIDDLE EAST: PHYSICAL TRANSFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)       119

TABLE 39           PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)          120

7.2.1      ELECTROPORATION    120

7.2.1.1   Growing demand for efficient cell transfection technologies to drive growth              120

TABLE 40           ELECTROPORATION MARKET, BY REGION, 2021–2028 (USD MILLION)          121

TABLE 41           NORTH AMERICA: ELECTROPORATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    121

TABLE 42           EUROPE: ELECTROPORATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     121

TABLE 43           ASIA PACIFIC: ELECTROPORATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          122

TABLE 44           LATIN AMERICA: ELECTROPORATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          122

TABLE 45           MIDDLE EAST & AFRICA: ELECTROPORATION MARKET, BY REGION, 2021–2028 (USD MILLION)       122

TABLE 46           MIDDLE EAST: ELECTROPORATION MARKET, BY REGION, 2021–2028 (USD MILLION)          123

7.2.2      BIOLISTIC TRANSFECTION/GENE GUNS            123

7.2.2.1   Increasing focus on rapid and simple techniques to support market growth              123

TABLE 47           BIOLISTIC TRANSFECTION/GENE GUNS MARKET, BY REGION, 2021–2028 (USD MILLION)          124

TABLE 48           NORTH AMERICA: BIOLISTIC TRANSFECTION/GENE GUNS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         124

TABLE 49           EUROPE: BIOLISTIC TRANSFECTION/GENE GUNS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    125

TABLE 50           ASIA PACIFIC: BIOLISTIC TRANSFECTION/GENE GUNS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         125

TABLE 51           LATIN AMERICA: BIOLISTIC TRANSFECTION/GENE GUNS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         126

TABLE 52           MIDDLE EAST & AFRICA: BIOLISTIC TRANSFECTION/GENE GUNS MARKET, BY REGION, 2021–2028 (USD MILLION) 126

TABLE 53           MIDDLE EAST: BIOLISTIC TRANSFECTION/GENE GUNS MARKET, BY REGION, 2021–2028 (USD MILLION)            126

7.2.3      MICROINJECTION         127

7.2.3.1   Rising need for advanced cell transfection techniques to drive adoption   127

TABLE 54           MICROINJECTION MARKET, BY REGION, 2021–2028 (USD MILLION)          127

TABLE 55           NORTH AMERICA: MICROINJECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          127

TABLE 56           EUROPE: MICROINJECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 128

TABLE 57           ASIA PACIFIC: MICROINJECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     128

TABLE 58           LATIN AMERICA: MICROINJECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          129

TABLE 59           MIDDLE EAST & AFRICA: MICROINJECTION MARKET, BY REGION, 2021–2028 (USD MILLION)       129

TABLE 60           MIDDLE EAST: MICROINJECTION MARKET, BY REGION, 2021–2028 (USD MILLION)     129

7.2.4      OTHER PHYSICAL TRANSFECTION METHODS  130

TABLE 61           OTHER PHYSICAL TRANSFECTION METHODS MARKET, BY REGION, 2021–2028 (USD MILLION)       130

TABLE 62           NORTH AMERICA: OTHER PHYSICAL TRANSFECTION METHODS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)   130

TABLE 63           EUROPE: OTHER PHYSICAL TRANSFECTION METHODS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         131

TABLE 64           ASIA PACIFIC: OTHER PHYSICAL TRANSFECTION METHODS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         131

TABLE 65           LATIN AMERICA: OTHER PHYSICAL TRANSFECTION METHODS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)   132

TABLE 66           MIDDLE EAST & AFRICA: OTHER PHYSICAL TRANSFECTION METHODS MARKET, BY REGION, 2021–2028 (USD MILLION)       132

TABLE 67           MIDDLE EAST: OTHER PHYSICAL TRANSFECTION METHODS MARKET, BY REGION, 2021–2028 (USD MILLION)            132

7.3         BIOCHEMICAL-BASED TRANSFECTION 133

TABLE 68           BIOCHEMICAL-BASED TRANSFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)          133

TABLE 69           NORTH AMERICA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         133

TABLE 70           EUROPE: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    134

TABLE 71          ASIA PACIFIC: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)            134

TABLE 72           LATIN AMERICA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         135

TABLE 73           MIDDLE EAST & AFRICA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)           135

TABLE 74           MIDDLE EAST: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)            135

TABLE 75           BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)          136

7.3.1      LIPOFECTION  136

7.3.1.1   High efficiency and compatibility to drive adoption     136

TABLE 76           LIPOFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)              137

TABLE 77           NORTH AMERICA: LIPOFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          137

TABLE 78           EUROPE: LIPOFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 137

TABLE 79           ASIA PACIFIC: LIPOFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 138

TABLE 80           LATIN AMERICA: LIPOFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     138

TABLE 81           MIDDLE EAST & AFRICA: LIPOFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)          138

TABLE 82           MIDDLE EAST: LIPOFECTION MARKET, BY REGION, 2021–2028 (USD MILLION) 139

7.3.2      CALCIUM PHOSPHATE TRANSFECTION             139

7.3.2.1   Increasing R&D in cell-based therapies to drive market             139

TABLE 83           CALCIUM PHOSPHATE TRANSFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)          140

TABLE 84           NORTH AMERICA: CALCIUM PHOSPHATE TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         140

TABLE 85           EUROPE: CALCIUM PHOSPHATE TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    141

TABLE 86           ASIA PACIFIC: CALCIUM PHOSPHATE TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         141

TABLE 87           LATIN AMERICA: CALCIUM PHOSPHATE TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         142

TABLE 88           MIDDLE EAST & AFRICA: CALCIUM PHOSPHATE TRANSFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)           142

TABLE 89           MIDDLE EAST: CALCIUM PHOSPHATE TRANSFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)            142

7.3.3      CATIONIC POLYMER TRANSFECTION   143

7.3.3.1   Adoption of innovative biochemical materials for transfection to accelerate growth              143

TABLE 90           CATIONIC POLYMER TRANSFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)          143

TABLE 91           NORTH AMERICA: CATIONIC POLYMER TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         144

TABLE 92           EUROPE: CATIONIC POLYMER TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    144

TABLE 93           ASIA PACIFIC: CATIONIC POLYMER TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)            145

TABLE 94           LATIN AMERICA: CATIONIC POLYMER TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         145

TABLE 95           MIDDLE EAST & AFRICA: CATIONIC POLYMER TRANSFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)            146

TABLE 96           MIDDLE EAST: CATIONIC POLYMER TRANSFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)  146

7.3.4      DEAE-DEXTRAN TRANSFECTION           146

7.3.4.1   Simplicity, rapidity, and cost-effectiveness to support adoption  146

TABLE 97           DEAE-DEXTRAN TRANSFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)     147

TABLE 98           NORTH AMERICA: DEAE-DEXTRAN TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)            147

TABLE 99           EUROPE: DEAE-DEXTRAN TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    148

TABLE 100         ASIA PACIFIC: DEAE-DEXTRAN TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    148

TABLE 101         LATIN AMERICA: DEAE-DEXTRAN TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)            149

TABLE 102         MIDDLE EAST & AFRICA: DEAE-DEXTRAN TRANSFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)            149

TABLE 103         MIDDLE EAST: DEAE-DEXTRAN TRANSFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)       149

7.3.5      MAGNET-ASSISTED TRANSFECTION     150

7.3.5.1   Rising emphasis on innovative therapies for genetic disorders to drive adoption              150

TABLE 104         MAGNET-ASSISTED TRANSFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)          150

TABLE 105         NORTH AMERICA: MAGNET-ASSISTED TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         150

TABLE 106         EUROPE: MAGNET-ASSISTED TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    151

TABLE 107         ASIA PACIFIC: MAGNET-ASSISTED TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)            151

TABLE 108         LATIN AMERICA: MAGNET-ASSISTED TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         152

TABLE 109         MIDDLE EAST & AFRICA: MAGNET-ASSISTED TRANSFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)            152

TABLE 110         MIDDLE EAST: MAGNET-ASSISTED TRANSFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)  152

7.3.6      DENDRIMER-MEDIATED TRANSFECTION          153

7.3.6.1   Non-biodegradable properties to restrain market growth           153

TABLE 111         DENDRIMER-MEDIATED TRANSFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)       153

TABLE 112         NORTH AMERICA: DENDRIMER-MEDIATED TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         153

TABLE 113         EUROPE: DENDRIMER-MEDIATED TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)            154

TABLE 114         ASIA PACIFIC: DENDRIMER-MEDIATED TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         154

TABLE 115         LATIN AMERICA: DENDRIMER-MEDIATED TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         155

TABLE 116         MIDDLE EAST & AFRICA: DENDRIMER-MEDIATED TRANSFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)           155

TABLE 117         MIDDLE EAST: DENDRIMER-MEDIATED TRANSFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)            155

7.4         VIRAL-VECTOR BASED TRANSFECTION             156

7.4.1      TECHNOLOGICAL DEVELOPMENTS AND GROWING NEED FOR CELL & GENE THERAPY TO DRIVE MARKET      156

TABLE 118         VIRAL VECTOR-BASED TRANSFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)          156

TABLE 119         NORTH AMERICA: VIRAL VECTOR-BASED TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         157

TABLE 120         EUROPE: VIRAL VECTOR-BASED TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    157

TABLE 121         ASIA PACIFIC: VIRAL VECTOR-BASED TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         158

TABLE 122         LATIN AMERICA: VIRAL VECTOR-BASED TRANSFECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         158

TABLE 123         MIDDLE EAST & AFRICA: VIRAL VECTOR-BASED TRANSFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)           159

TABLE 124         MIDDLE EAST: VIRAL VECTOR-BASED TRANSFECTION MARKET, BY REGION, 2021–2028 (USD MILLION)            159

8            TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION   160

8.1         INTRODUCTION            161

TABLE 125         TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)          161

8.2         THERAPEUTIC DELIVERY          162

TABLE 126         TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY REGION, 2021–2028 (USD MILLION)          162

TABLE 127         NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY COUNTRY, 2021–2028 (USD MILLION)              162

TABLE 128         EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY COUNTRY, 2021–2028 (USD MILLION)       163

TABLE 129         ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY COUNTRY, 2021–2028 (USD MILLION)       163

TABLE 130         LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY COUNTRY, 2021–2028 (USD MILLION)              164

TABLE 131         MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY REGION, 2021–2028 (USD MILLION)              164

TABLE 132         MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY REGION, 2021–2028 (USD MILLION)           164

TABLE 133         TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION) 165

8.2.1      BIOTHERAPEUTICS       165

8.2.1.1   Rising need for cell and gene therapy to promote growth           165

TABLE 134         TRANSFECTION TECHNOLOGIES MARKET FOR BIOTHERAPEUTICS, BY REGION, 2021–2028 (USD MILLION)       165

TABLE 135         NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOTHERAPEUTICS, BY COUNTRY, 2021–2028 (USD MILLION)         166

TABLE 136         EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR BIOTHERAPEUTICS, BY COUNTRY, 2021–2028 (USD MILLION)   166

TABLE 137         ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR BIOTHERAPEUTICS, BY COUNTRY, 2021–2028 (USD MILLION)   167

TABLE 138         LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOTHERAPEUTICS, BY COUNTRY, 2021–2028 (USD MILLION)         167

TABLE 139         MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOTHERAPEUTICS, BY REGION, 2021–2028 (USD MILLION)              168

TABLE 140         MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR BIOTHERAPEUTICS, BY REGION, 2021–2028 (USD MILLION)       168

8.2.2      ELECTROIMMUNOTHERAPY    168

8.2.2.1   Increasing rate of chronic and immunological diseases to accelerate market growth              168

TABLE 141         TRANSFECTION TECHNOLOGIES MARKET FOR ELECTROIMMUNOTHERAPY, BY REGION, 2021–2028 (USD MILLION)     169

TABLE 142         NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR ELECTROIMMUNOTHERAPY, BY COUNTRY, 2021–2028 (USD MILLION)              169

TABLE 143         EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR ELECTROIMMUNOTHERAPY, BY COUNTRY, 2021–2028 (USD MILLION) 170

TABLE 144         ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR ELECTROIMMUNOTHERAPY, BY COUNTRY, 2021–2028 (USD MILLION) 170

TABLE 145         LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR ELECTROIMMUNOTHERAPY, BY COUNTRY, 2021–2028 (USD MILLION)              171

TABLE 146         MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR ELECTROIMMUNOTHERAPY, BY REGION, 2021–2028 (USD MILLION)          171

TABLE 147         MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR ELECTROIMMUNOTHERAPY, BY REGION, 2021–2028 (USD MILLION)     171

8.2.3      ELECTROCHEMOTHERAPY       172

8.2.3.1   Need for advanced chemotherapy due to rising cancer incidence to drive market              172

TABLE 148         TRANSFECTION TECHNOLOGIES MARKET FOR ELECTROCHEMOTHERAPY, BY REGION, 2021–2028 (USD MILLION)        172

TABLE 149         NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR ELECTROCHEMOTHERAPY, BY COUNTRY, 2021–2028 (USD MILLION)              172

TABLE 150         EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR ELECTROCHEMOTHERAPY, BY COUNTRY, 2021–2028 (USD MILLION)    173

TABLE 151         ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR ELECTROCHEMOTHERAPY, BY COUNTRY, 2021–2028 (USD MILLION)    173

TABLE 152         LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR ELECTROCHEMOTHERAPY, BY COUNTRY, 2021–2028 (USD MILLION)              174

TABLE 153         MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR ELECTROCHEMOTHERAPY, BY REGION, 2021–2028 (USD MILLION)          174

TABLE 154         MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR ELECTROCHEMOTHERAPY, BY REGION, 2021–2028 (USD MILLION)        174

8.3         BIOMEDICAL RESEARCH            175

TABLE 155         TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY REGION, 2021–2028 (USD MILLION)         175

TABLE 156         NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 175

TABLE 157         EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)        176

TABLE 158         ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)        176

TABLE 159         LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION) 177

TABLE 160         MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY REGION, 2021–2028 (USD MILLION)              177

TABLE 161         MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY REGION, 2021–2028 (USD MILLION)            177

TABLE 162         TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION) 178

8.3.1      GENE & PROTEIN EXPRESSION STUDIES            178

8.3.1.1   Efforts to develop advanced gene therapy and genomic medicine promote growth              178

TABLE 163         TRANSFECTION TECHNOLOGIES MARKET FOR GENE & PROTEIN EXPRESSION STUDIES, BY REGION, 2021–2028 (USD MILLION)              179

TABLE 164         NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR GENE & PROTEIN EXPRESSION STUDIES, BY COUNTRY, 2021–2028 (USD MILLION)          179

TABLE 165         EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR GENE & PROTEIN EXPRESSION STUDIES, BY COUNTRY, 2021–2028 (USD MILLION)          180

TABLE 166         ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR GENE & PROTEIN EXPRESSION STUDIES, BY COUNTRY, 2021–2028 (USD MILLION)          180

TABLE 167         LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR GENE & PROTEIN EXPRESSION STUDIES, BY COUNTRY, 2021–2028 (USD MILLION)          181

TABLE 168         MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR GENE & PROTEIN EXPRESSION STUDIES, BY REGION, 2021–2028 (USD MILLION) 181

TABLE 169         MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR GENE & PROTEIN EXPRESSION STUDIES, BY REGION, 2021–2028 (USD MILLION)              181

8.3.2      CANCER RESEARCH      182

8.3.2.1   Increasing prevalence of cancer to propel market growth           182

TABLE 170         TRANSFECTION TECHNOLOGIES MARKET FOR CANCER RESEARCH, BY REGION, 2021–2028 (USD MILLION)         182

TABLE 171         NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR CANCER RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)         182

TABLE 172         EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR CANCER RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)   183

TABLE 173         ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR CANCER RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)   183

TABLE 174         LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR CANCER RESEARCH, BY COUNTRY, 2021–2028 (USD MILLION)         184

TABLE 175         MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR CANCER RESEARCH, BY REGION, 2021–2028 (USD MILLION)              184

TABLE 176         MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR CANCER RESEARCH, BY REGION, 2021–2028 (USD MILLION)       184

8.3.3      TRANSGENIC MODELS 185

8.3.3.1   Growing R&D activities and clinical studies to drive market       185

TABLE 177         TRANSFECTION TECHNOLOGIES MARKET FOR TRANSGENIC MODELS, BY REGION, 2021–2028 (USD MILLION)            185

TABLE 178         NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR TRANSGENIC MODELS, BY COUNTRY, 2021–2028 (USD MILLION)   185

TABLE 179         EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR TRANSGENIC MODELS, BY COUNTRY, 2021–2028 (USD MILLION)            186

TABLE 180         ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR TRANSGENIC MODELS, BY COUNTRY, 2021–2028 (USD MILLION)            186

TABLE 181         LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR TRANSGENIC MODELS, BY COUNTRY, 2021–2028 (USD MILLION)   187

TABLE 182         MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR TRANSGENIC MODELS, BY REGION, 2021–2028 (USD MILLION)              187

TABLE 183         MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR TRANSGENIC MODELS, BY REGION, 2021–2028 (USD MILLION) 187

8.4         PROTEIN PRODUCTION             188

8.4.1      INCREASING INCIDENCE OF CHRONIC DISEASES AND DEMAND FOR PROTEIN THERAPEUTICS TO PROMOTE GROWTH        188

TABLE 184         TRANSFECTION TECHNOLOGIES MARKET FOR PROTEIN PRODUCTION, BY REGION, 2021–2028 (USD MILLION)  188

TABLE 185         NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR PROTEIN PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION) 189

TABLE 186         EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR PROTEIN PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION)         189

TABLE 187         ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR PROTEIN PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION)         190

TABLE 188         LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR PROTEIN PRODUCTION, BY COUNTRY, 2021–2028 (USD MILLION) 190

TABLE 189         MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR PROTEIN PRODUCTION, BY REGION, 2021–2028 (USD MILLION)              191

TABLE 190         MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR PROTEIN PRODUCTION, BY REGION, 2021–2028 (USD MILLION)             191

8.5         CELL-BASED MICROARRAYS     191

8.5.1      INCREASING NEED FOR CELL-BASED THERAPIES TO DRIVE MARKET              191

TABLE 191         TRANSFECTION TECHNOLOGIES MARKET FOR CELL-BASED MICROARRAYS, BY REGION, 2021–2028 (USD MILLION) 192

TABLE 192         NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR CELL-BASED MICROARRAYS, BY COUNTRY, 2021–2028 (USD MILLION)              192

TABLE 193         EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR CELL-BASED MICROARRAYS, BY COUNTRY, 2021–2028 (USD MILLION)  193

TABLE 194         ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR CELL-BASED MICROARRAYS, BY COUNTRY, 2021–2028 (USD MILLION)  193

TABLE 195         LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR CELL-BASED MICROARRAYS, BY COUNTRY, 2021–2028 (USD MILLION)              194

TABLE 196         MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR CELL-BASED MICROARRAYS, BY REGION, 2021–2028 (USD MILLION)          194

TABLE 197         MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR CELL-BASED MICROARRAYS, BY REGION, 2021–2028 (USD MILLION)      194

9            TRANSFECTION TECHNOLOGIES MARKET, BY END USER          195

9.1         INTRODUCTION            196

TABLE 198         TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)          196

9.2         PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES   196

9.2.1      PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE END-USER MARKET      196

TABLE 199         TRANSFECTION TECHNOLOGIES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION) 197

TABLE 200         NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)          197

TABLE 201         EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 198

TABLE 202         ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 198

TABLE 203         LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)          199

TABLE 204         MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION)       199

TABLE 205         MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION) 199

9.3         CROS & CDMOS              200

9.3.1      CONTRACT RESEARCH AND MANUFACTURING SECTOR TO SEE STRONG GROWTH        200

TABLE 206         TRANSFECTION TECHNOLOGIES MARKET FOR CROS & CDMOS, BY REGION, 2021–2028 (USD MILLION) 200

TABLE 207         NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR CROS & CDMOS, BY COUNTRY, 2021–2028 (USD MILLION)  201

TABLE 208         EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR CROS & CDMOS, BY COUNTRY, 2021–2028 (USD MILLION)       201

TABLE 209         ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR CROS & CDMOS, BY COUNTRY, 2021–2028 (USD MILLION)          202

TABLE 210         LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR CROS & CDMOS, BY COUNTRY, 2021–2028 (USD MILLION)  202

TABLE 211         MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR CROS & CDMOS, BY REGION, 2021–2028 (USD MILLION)   203

TABLE 212         MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR CROS & CDMOS, BY REGION, 2021–2028 (USD MILLION) 203

9.4         ACADEMIC & RESEARCH INSTITUTES   203

9.4.1      INCREASING R&D AND GROWING TREND OF COLLABORATIVE RESEARCH TO PROMOTE MARKET GROWTH    203

TABLE 213         TRANSFECTION TECHNOLOGIES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION) 204

TABLE 214         NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)          204

TABLE 215         EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)              205

TABLE 216         ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)              205

TABLE 217         LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)          206

TABLE 218         MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION) 206

TABLE 219         MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION)              206

9.5         OTHER END USERS        207

TABLE 220         TRANSFECTION TECHNOLOGIES MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)   207

TABLE 221         NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)         207

TABLE 222         EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)    208

TABLE 223         ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)    208

TABLE 224         LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)         209

TABLE 225         MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)              209

TABLE 226         MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)        209

10          TRANSFECTION TECHNOLOGIES MARKET, BY REGION 210

10.1       INTRODUCTION            211

TABLE 227         TRANSFECTION TECHNOLOGIES MARKET, BY REGION, 2021–2028 (USD MILLION)     211

10.2       NORTH AMERICA          211

10.2.1    NORTH AMERICA: RECESSION IMPACT 212

FIGURE 30         NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET SNAPSHOT        213

TABLE 228         NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)            213

TABLE 229         NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)            214

TABLE 230         NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)             214

TABLE 231         NORTH AMERICA: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)             214

TABLE 232         NORTH AMERICA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)    215

TABLE 233         NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)     215

TABLE 234         NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)       216

TABLE 235         NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)         216

TABLE 236         NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)            217

10.2.2    US         217

10.2.2.1 US to dominate North American market        217

TABLE 237         US: INDICATIVE LIST OF THERAPIES APPROVED IN 2022              218

TABLE 238         US: INDICATIVE LIST OF PRODUCTS ANTICIPATED TO BE APPROVED IN 2023        218

TABLE 239         US: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)          218

TABLE 240         US: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)          219

TABLE 241         US: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION) 219

TABLE 242         US: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)          220

TABLE 243         US: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)           220

TABLE 244         US: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)  221

TABLE 245         US: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)   221

TABLE 246         US: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)          221

10.2.3    CANADA            222

10.2.3.1 Rising investments in R&D to drive market    222

TABLE 247         CANADA: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   222

TABLE 248         CANADA: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)     222

TABLE 249         CANADA: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)     223

TABLE 250         CANADA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)             223

TABLE 251         CANADA: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)           224

TABLE 252         CANADA: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)  224

TABLE 253         CANADA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)   224

TABLE 254         CANADA: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)             225

10.3       EUROPE             225

TABLE 255         EUROPE: INDICATIVE LIST OF THERAPIES APPROVED IN 2022              225

TABLE 256         EUROPE: INDICATIVE LIST OF PRODUCTS ANTICIPATED TO BE APPROVED IN 2023  225

10.3.1    EUROPE: RECESSION IMPACT   226

TABLE 257         EUROPE: TRANSFECTION TECHNOLOGIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    226

TABLE 258         EUROPE: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   227

TABLE 259         EUROPE: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)     227

TABLE 260         EUROPE: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)     227

TABLE 261         EUROPE: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)             228

TABLE 262         EUROPE: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)           228

TABLE 263         EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)  229

TABLE 264         EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)   229

TABLE 265         EUROPE: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)             230

10.3.2    GERMANY         230

10.3.2.1 Germany to hold largest share of European market till 2028      230

TABLE 266         GERMANY: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   230

TABLE 267         GERMANY: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)     231

TABLE 268         GERMANY: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)          231

TABLE 269         GERMANY: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)       232

TABLE 270         GERMANY: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)           232

TABLE 271         GERMANY: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)  233

TABLE 272         GERMANY: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)   233

TABLE 273         GERMANY: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)             233

10.3.3    UK         234

10.3.3.1 Increasing government funding for genomic projects to drive market       234

TABLE 274         UK: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)          234

TABLE 275         UK: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)          234

TABLE 276         UK: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION) 235

TABLE 277         UK: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)          235

TABLE 278         UK: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)           236

TABLE 279         UK: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)  236

TABLE 280         UK: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)   236

TABLE 281         UK: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)          237

10.3.4    FRANCE             237

10.3.4.1 Focus on collaborative development of advanced cell and gene therapies to promote market growth     237

TABLE 282         FRANCE: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   238

TABLE 283         FRANCE: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)     238

TABLE 284         FRANCE: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)     238

TABLE 285         FRANCE: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)             239

TABLE 286         FRANCE: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)           239

TABLE 287         FRANCE: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)  240

TABLE 288         FRANCE: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)   240

TABLE 289         FRANCE: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)             241

10.3.5    ITALY   241

10.3.5.1 Rising R&D investments and growing biotech industry to drive market    241

TABLE 290         ITALY: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   241

TABLE 291         ITALY: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)     242

TABLE 292         ITALY: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)     242

TABLE 293         ITALY: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)             243

TABLE 294         ITALY: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)           243

TABLE 295         ITALY: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)  244

TABLE 296         ITALY: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)   244

TABLE 297         ITALY: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)             245

10.3.6    SPAIN   245

10.3.6.1 Growing expansion of research centers to stimulate market growth          245

TABLE 298         SPAIN: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   246

TABLE 299         SPAIN: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)     246

TABLE 300         SPAIN: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)     246

TABLE 301         SPAIN: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)             247

TABLE 302         SPAIN: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)           247

TABLE 303         SPAIN: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)  248

TABLE 304         SPAIN: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)   248

TABLE 305         SPAIN: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)             248

10.3.7    REST OF EUROPE           249

TABLE 306         REST OF EUROPE: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)            249

TABLE 307         REST OF EUROPE: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)             249

TABLE 308         REST OF EUROPE: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)             250

TABLE 309         REST OF EUROPE: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)    250

TABLE 310         REST OF EUROPE: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)     251

TABLE 311         REST OF EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)       251

TABLE 312         REST OF EUROPE: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)         251

TABLE 313         REST OF EUROPE: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)            252

10.4       ASIA PACIFIC    252

10.4.1    ASIA PACIFIC: RECESSION IMPACT        253

FIGURE 31         ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SNAPSHOT        254

TABLE 314         ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    255

TABLE 315         ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   255

TABLE 316         ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)     256

TABLE 317         ASIA PACIFIC: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)          256

TABLE 318        ASIA PACIFIC: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)       257

TABLE 319         ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)           257

TABLE 320         ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)  258

TABLE 321         ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)   258

TABLE 322         ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)    259

10.4.2    CHINA  259

10.4.2.1 Increasing R&D expenditure to propel market growth  259

TABLE 323         CHINA: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   260

TABLE 324         CHINA: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)     260

TABLE 325         CHINA: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)     260

TABLE 326         CHINA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)             261

TABLE 327         CHINA: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)           261

TABLE 328         CHINA: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)  262

TABLE 329         CHINA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)   262

TABLE 330         CHINA: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)             262

10.4.3    JAPAN  263

10.4.3.1 Booming CGT & RM sector to drive market  263

TABLE 331         JAPAN: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   263

TABLE 332         JAPAN: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)     264

TABLE 333         JAPAN: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)     264

TABLE 334         JAPAN: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)             265

TABLE 335         JAPAN: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)           265

TABLE 336         JAPAN: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)  266

TABLE 337         JAPAN: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)   266

TABLE 338         JAPAN: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)             267

10.4.4    SOUTH KOREA 267

10.4.4.1 Alliances and investments in research to drive market  267

TABLE 339         SOUTH KOREA: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   268

TABLE 340         SOUTH KOREA: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)     268

TABLE 341         SOUTH KOREA: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)          268

TABLE 342         SOUTH KOREA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)    269

TABLE 343         SOUTH KOREA: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)           269

TABLE 344         SOUTH KOREA: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)       270

TABLE 345         SOUTH KOREA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)         270

TABLE 346         SOUTH KOREA: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)    270

10.4.5    INDIA   271

10.4.5.1 Growing demand for advanced treatment solutions to propel market growth              271

TABLE 347         INDIA: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   271

TABLE 348         INDIA: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)     271

TABLE 349         INDIA: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)     272

TABLE 350         INDIA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)             272

TABLE 351         INDIA: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)           273

TABLE 352         INDIA: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)  273

TABLE 353         INDIA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)   273

TABLE 354         INDIA: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)             274

10.4.6    AUSTRALIA       274

10.4.6.1 Rising prevalence of chronic diseases and growing life science sector to drive market   274

TABLE 355         AUSTRALIA: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   275

TABLE 356         AUSTRALIA: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)     275

TABLE 357         AUSTRALIA: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)          275

TABLE 358         AUSTRALIA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)       276

TABLE 359         AUSTRALIA: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)           276

TABLE 360         AUSTRALIA: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)  277

TABLE 361         AUSTRALIA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)   277

TABLE 362         AUSTRALIA: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)    277

10.4.7    REST OF ASIA PACIFIC  278

TABLE 363         REST OF ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)        278

TABLE 364         REST OF ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)          278

TABLE 365         REST OF ASIA PACIFIC: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)             279

TABLE 366         REST OF ASIA PACIFIC: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)    279

TABLE 367         REST OF ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)  280

TABLE 368         REST OF ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)              280

TABLE 369         REST OF ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)              280

TABLE 370         REST OF ASIA PACIFIC: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)         281

10.5       LATIN AMERICA             281

10.5.1    LATIN AMERICA: RECESSION IMPACT   281

TABLE 371         LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)            282

TABLE 372         LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)            282

TABLE 373         LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)             282

TABLE 374        LATIN AMERICA: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)          283

TABLE 375         LATIN AMERICA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)    283

TABLE 376         LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)     284

TABLE 377         LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)       284

TABLE 378         LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)         284

TABLE 379         LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)            285

10.5.2    BRAZIL 285

10.5.2.1 Brazil to hold largest share of LATAM market             285

TABLE 380         BRAZIL: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   285

TABLE 381         BRAZIL: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)     286

TABLE 382         BRAZIL: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)     286

TABLE 383         BRAZIL: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)             287

TABLE 384         BRAZIL: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)           287

TABLE 385         BRAZIL: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)  288

TABLE 386         BRAZIL: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)   288

TABLE 387         BRAZIL: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)             288

10.5.3    MEXICO             289

10.5.3.1 Rising research activity to support market growth        289

TABLE 388         MEXICO: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   289

TABLE 389         MEXICO: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)     289

TABLE 390         MEXICO: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)     290

TABLE 391         MEXICO: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)             290

TABLE 392         MEXICO: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)           291

TABLE 393         MEXICO: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)  291

TABLE 394         MEXICO: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)   291

TABLE 395         MEXICO: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)             292

10.5.4    ARGENTINA      292

10.5.4.1 Increasing government initiatives to drive market        292

TABLE 396         ARGENTINA: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   292

TABLE 397         ARGENTINA: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)     293

TABLE 398         ARGENTINA: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)          293

TABLE 399         ARGENTINA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)       294

TABLE 400         ARGENTINA: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)           294

TABLE 401         ARGENTINA: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)  295

TABLE 402         ARGENTINA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)   295

TABLE 403         ARGENTINA: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)    296

10.5.5    REST OF LATIN AMERICA          296

TABLE 404         REST OF LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)        296

TABLE 405         REST OF LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)          297

TABLE 406         REST OF LATIN AMERICA: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)       297

TABLE 407         REST OF LATIN AMERICA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)  298

TABLE 408         REST OF LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)  298

TABLE 409         REST OF LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)              299

TABLE 410         REST OF LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)              299

TABLE 411         REST OF LATIN AMERICA: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)         299

10.6       MIDDLE EAST & AFRICA             300

10.6.1    MIDDLE EAST & AFRICA: RECESSION IMPACT   300

TABLE 412         MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET, BY REGION, 2021–2028 (USD MILLION)            300

TABLE 413         MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)        301

TABLE 414         MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)          301

TABLE 415         MIDDLE EAST & AFRICA: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)       301

TABLE 416         MIDDLE EAST & AFRICA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)  302

TABLE 417         MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)  302

TABLE 418         MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)              303

TABLE 419         MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)              303

TABLE 420         MIDDLE EAST & AFRICA: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)         303

10.6.2    MIDDLE EAST  304

TABLE 421         MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET, BY REGION, 2021–2028 (USD MILLION)       304

TABLE 422         MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   305

TABLE 423         MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)     305

TABLE 424         MIDDLE EAST: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)          306

TABLE 425         MIDDLE EAST: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)    306

TABLE 426         MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)           307

TABLE 427         MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)  307

TABLE 428         MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)   307

TABLE 429         MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)    308

10.6.2.1 GCC Countries    308

10.6.2.1.1            Increasing collaborations and partnerships to advance cell therapy to drive market        308

TABLE 430         GCC COUNTRIES: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)            308

TABLE 431         GCC COUNTRIES: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)             309

TABLE 432         GCC COUNTRIES: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)             309

TABLE 433         GCC COUNTRIES: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)    310

TABLE 434         GCC COUNTRIES: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)     310

TABLE 435         GCC COUNTRIES: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)       311

TABLE 436         GCC COUNTRIES: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)         311

TABLE 437         GCC COUNTRIES: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)            311

10.6.2.2 Rest of the Middle East      312

TABLE 438         REST OF MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)        312

TABLE 439         REST OF MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)          312

TABLE 440         REST OF MIDDLE EAST: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)       313

TABLE 441         REST OF MIDDLE EAST: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)  313

TABLE 442         REST OF MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)  314

TABLE 443         REST OF MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)              314

TABLE 444         REST OF MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)              314

TABLE 445         REST OF MIDDLE EAST: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)         315

10.6.3    AFRICA 315

10.6.3.1 Rising prevalence of HIV and cancer and growing precision medicine initiatives to fuel market growth             315

TABLE 446         AFRICA: TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   316

TABLE 447         AFRICA: TRANSFECTION TECHNOLOGIES MARKET, BY METHOD, 2021–2028 (USD MILLION)     316

TABLE 448         AFRICA: PHYSICAL TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)     316

TABLE 449         AFRICA: BIOCHEMICAL-BASED TRANSFECTION MARKET, BY TYPE, 2021–2028 (USD MILLION)             317

TABLE 450         AFRICA: TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION, 2021–2028 (USD MILLION)           317

TABLE 451         AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR THERAPEUTIC DELIVERY, BY TYPE, 2021–2028 (USD MILLION)  318

TABLE 452         AFRICA: TRANSFECTION TECHNOLOGIES MARKET FOR BIOMEDICAL RESEARCH, BY TYPE, 2021–2028 (USD MILLION)   318

TABLE 453         AFRICA: TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2021–2028 (USD MILLION)             318

11          COMPETITIVE LANDSCAPE       319

11.1       OVERVIEW        319

11.2       KEY PLAYER STRATEGIES/RIGHT TO WIN          319

11.3       REVENUE SHARE ANALYSIS       320

11.4       MARKET SHARE ANALYSIS         321

FIGURE 34         TRANSFECTION TECHNOLOGIES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022    321

TABLE 454         TRANSFECTION TECHNOLOGIES MARKET: DEGREE OF COMPETITION 322

11.5       COMPANY EVALUATION MATRIX: KEY PLAYERS            323

11.5.1    STARS  323

11.5.2    EMERGING LEADERS    323

11.5.3    PERVASIVE PLAYERS     323

11.5.4    PARTICIPANTS 323

11.5.5    COMPANY FOOTPRINT 324

TABLE 455         COMPANY FOOTPRINT 324

TABLE 456         COMPANY PRODUCT FOOTPRINT         325

TABLE 457         COMPANY REGION FOOTPRINT             326

11.6       COMPANY EVALUATION MATRIX: STARTUPS/SMES      327

11.6.1    PROGRESSIVE COMPANIES       327

11.6.2    RESPONSIVE COMPANIES          327

11.6.3    DYNAMIC COMPANIES 328

11.6.4    STARTING BLOCKS       328

FIGURE 36         TRANSFECTION TECHNOLOGIES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES) (2022)            328

11.6.5    COMPETITIVE BENCHMARKING            329

TABLE 458         TRANSFECTION TECHNOLOGIES MARKET: KEY STARTUPS/SMES           329

TABLE 459         TRANSFECTION TECHNOLOGIES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES        330

11.7       COMPETITIVE SCENARIO          331

11.7.1    PRODUCT LAUNCHES  331

TABLE 460         TRANSFECTION TECHNOLOGIES MARKET: KEY PRODUCT LAUNCHES, JANUARY 2020−DECEMBER 2023    331

11.7.2    DEALS  332

TABLE 461         TRANSFECTION TECHNOLOGIES MARKET: KEY DEALS, JANUARY 2020− DECEMBER 2023           332

11.7.3    OTHER DEVELOPMENTS           332

TABLE 462         TRANSFECTION TECHNOLOGIES MARKET: OTHER DEVELOPMENTS, JANUARY 2020−NOVEMBER 2023       332

12          COMPANY PROFILES    333

12.1       KEY PLAYERS   333

(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*

12.1.1    THERMO FISHER SCIENTIFIC INC.          333

TABLE 463         THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW              333

FIGURE 37         THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022)   334

TABLE 464         THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED              334

TABLE 465         THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES              337

TABLE 466         THERMO FISHER SCIENTIFIC INC.: DEALS          337

TABLE 467         THERMO FISHER SCIENTIFIC INC.: OTHER DEVELOPMENTS              337

12.1.2    BIO-RAD LABORATORIES, INC. 339

TABLE 468         BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW   339

FIGURE 38         BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022)              340

TABLE 469         BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED   340

12.1.3    QIAGEN             342

TABLE 470         QIAGEN: BUSINESS OVERVIEW 342

FIGURE 39         QIAGEN: COMPANY SNAPSHOT (2022)  343

TABLE 471         QIAGEN: PRODUCTS OFFERED 343

12.1.4    MERCK KGAA   345

TABLE 472         MERCK KGAA: BUSINESS OVERVIEW     345

FIGURE 40         MERCK KGAA: COMPANY SNAPSHOT (2022)      346

TABLE 473         MERCK KGAA: PRODUCTS OFFERED     346

TABLE 474         MERCK KGAA: DEALS   347

TABLE 475         MERCK KGAA: OTHER DEVELOPMENTS             348

12.1.5    SARTORIUS AG (POLYPLUS)     349

TABLE 476         SARTORIUS AG (POLYPLUS): BUSINESS OVERVIEW        349

FIGURE 41         SARTORIUS AG (POLYPLUS): COMPANY SNAPSHOT (2022)              350

TABLE 477         SARTORIUS AG (POLYPLUS): PRODUCTS OFFERED       350

TABLE 478         SARTORIUS AG (POLYPLUS): PRODUCT LAUNCHES      351

TABLE 479         SARTORIUS AG (POLYPLUS): DEALS      352

12.1.6    LONZA 353

TABLE 480         LONZA: BUSINESS OVERVIEW   353

FIGURE 42         LONZA: COMPANY SNAPSHOT (2022)    354

TABLE 481         LONZA: PRODUCTS OFFERED  354

TABLE 482         LONZA: PRODUCT LAUNCHES 356

TABLE 483         LONZA: DEALS 356

12.1.7    F. HOFFMANN-LA ROCHE LTD. 357

TABLE 484         F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW  357

FIGURE 43         F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2022)              358

TABLE 485         F. HOFFMAN-LA ROCHE LTD.: PRODUCTS OFFERED     358

12.1.8    AGILENT TECHNOLOGIES, INC.             360

TABLE 486         AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW 360

FIGURE 44         AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022)              361

TABLE 487         AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED 361

TABLE 488         AGILENT TECHNOLOGIES, INC.: DEALS             362

12.1.9    MAXCYTE          363

TABLE 489         MAXCYTE: BUSINESS OVERVIEW            363

FIGURE 45         MAXCYTE: COMPANY SNAPSHOT (2022)            363

TABLE 490         MAXCYTE: PRODUCTS OFFERED           364

TABLE 491         MAXCYTE: PRODUCT LAUNCHES          364

TABLE 492         MAXCYTE: DEALS          364

12.1.10  REVVITY            366

TABLE 493         REVVITY: BUSINESS OVERVIEW 366

FIGURE 46         REVVITY: COMPANY SNAPSHOT (2022) 367

TABLE 494         REVVITY: PRODUCTS OFFERED             367

TABLE 495         REVVITY: DEALS            368

TABLE 496         REVVITY: OTHER DEVELOPMENTS       368

12.1.11  TAKARA BIO INC.           369

TABLE 497         TAKARA BIO INC.: BUSINESS OVERVIEW             369

FIGURE 47         TAKARA BIO INC.: COMPANY SNAPSHOT (2022)             370

TABLE 498         TAKARA BIO INC.: COMPANY OVERVIEW           371

12.1.12  PROMEGA CORPORATION        372

TABLE 499         PROMEGA CORPORATION: BUSINESS OVERVIEW          372

TABLE 500         PROMEGA CORPORATION: PRODUCTS OFFERED          373

12.1.13  DANAHER CORPORATION         374

TABLE 501         DANAHER CORPORATION: BUSINESS OVERVIEW           374

FIGURE 48         DANAHER CORPORATION: COMPANY SNAPSHOT (2022)              375

TABLE 502         DANAHER CORPORATION: PRODUCTS OFFERED          375

TABLE 503         DANAHER CORPORATION: PRODUCT LAUNCHES         376

TABLE 504         DANAHER CORPORATION: DEALS         376

TABLE 505         DANAHER CORPORATION: OTHER DEVELOPMENTS    376

12.2       OTHER PLAYERS           377

12.2.1    BOC SCIENCES 377

TABLE 506         BOC SCIENCES: COMPANY OVERVIEW  377

12.2.2    RJH BIOSCIENCES          379

TABLE 507         RJH BIOSCIENCES: COMPANY OVERVIEW          379

12.2.3    SYNVOLUX        380

TABLE 508         SYNVOLUX: COMPANY OVERVIEW        380

12.2.4    ALTOGEN BIOSYSTEMS 381

TABLE 509         ALTOGEN BIOSYSTEMS: COMPANY OVERVIEW 381

12.2.5    BIOIVT 382

TABLE 510         BIOIVT: COMPANY OVERVIEW 382

12.2.6    INCELLA GMBH             383

TABLE 511         INCELLA GMBH (SCREENFECT): COMPANY OVERVIEW 383

12.2.7    INVIVOGEN      384

TABLE 512         INVIVOGEN: COMPANY OVERVIEW       384

12.2.8    PHOREUS BIOTECH      385

TABLE 513         PHOREUS BIOTECH: COMPANY OVERVIEW       385

12.2.9    STEMCELL TECHNOLOGIES      386

TABLE 514         STEMCELL TECHNOLOGIES: COMPANY OVERVIEW      386

12.2.10  EZ BIOSYSTEMS             387

TABLE 515         EZ BIOSYSTEMS: COMPANY OVERVIEW 387

12.2.11  OZ BIOSCIENCES           388

TABLE 516         OZ BIOSCIENCES: COMPANY OVERVIEW            388

12.2.12  CHEMICELL GMBH       389

TABLE 517         CHEMICELL GMBH: COMPANY OVERVIEW        389

*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

13          APPENDIX         390

13.1       DISCUSSION GUIDE      390

13.2       KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL             396

13.3       CUSTOMIZATION OPTIONS      398

13.4       RELATED REPORTS       398

13.5       AUTHOR DETAILS         399